Ethanol → HCID 137194585, compound

HRID 731359Notes

Reaction equation

HRID 731359 reaction equation
[CH3:1][S:2]([NH:5][C:6]1[CH:21]=[CH:20][C:9]2[NH:10][C:11]([CH2:16][C:17](O)=[O:18])=[N:12][S:13](=[O:15])(=[O:14])[C:8]=2[CH:7]=1)(=[O:4])=[O:3].C(O[C:25]([CH:27]1[CH2:31][CH2:30][CH2:29][CH:28]1[NH:32][C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=1)=[O:26])C.CN1CCOCC1.Cl.CN(C)CCCN=C=NCC.[O-]CC.[Na+].C(O)C>CN(C)C=O.C(O)(=O)C>[OH:26][C:25]1[C@H:27]2[C@H:28]([CH2:29][CH2:30][CH2:31]2)[N:32]([C:33]2[CH:34]=[CH:35][CH:36]=[CH:37][CH:38]=2)[C:17](=[O:18])[C:16]=1[C:11]1[NH:10][C:9]2[CH:20]=[CH:21][C:6]([NH:5][S:2]([CH3:1])(=[O:4])=[O:3])=[CH:7][C:8]=2[S:13](=[O:15])(=[O:14])[N:12]=1

Participants

9

Conditions

Temperature
25 °C

Procedure

A solution of (7-methanesulfonylamino-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4] thiadiazin-3-yl)-acetic acid (prepared as described in Example 1j, 0.100 g, 0.300 mmol) and 2-phenylamino-cyclopentanecarboxylic acid ethyl ester (0.070 g, 0.300 mmol) in N,N-dimethylformamide (1.5 mL) was treated with N-methylmorpholine (72.8 mg, 0.72 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbo-diimide hydrochloride (69.0 mg, 0.36 mmol) and stirred at 25° C. for 4 h. The solvent was removed in vacuo. The crude material was redissolved in ethyl acetate (75 mL) and washed twice with 1.0 M aqueous hydrochloric acid solution (50 mL). The organic layer was then dried over sodium sulfate, filtered and concentrated in vacuo. The crude intermediate was redissolved in ethanol (5 mL) and treated with a 21% w/w solution of sodium ethoxide in ethanol (448 μL, 1.2 mmol) and stirred for 2 h at 60° C. The reaction was allowed to cool to 25° C., treated with glacial acetic acid (0.4 mL), the solvents were removed in vacuo, and the residue was and purified by prep-HPLC [Column Luna 5μ C18 (2) 100 Å AXIA 50×21.2 mm, 5 micron, 30%-90% in 7 min @ 30 mL/min flow rate, 0.05% trifluoroacetic acid in acetonitrile/0.05% trifluoroacetic acid in water] to afford the desired product, cis-N-[3-(4-Hydroxy-2-oxo-1-phenyl-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl)-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl]-methanesulfonamide (25 mg, 0.050 mmol, 16.6%), as a white solid. 1H NMR (400 MHz, CDCl3) δ: 1.65-1.72 (1H, m), 1.76-1.88 (2H, m), 1.93-2.00 (1H, m), 2.26-2.31 (2H, m), 3.04 (3H, s), 3.26 (1H, dd, J1=15.5 Hz, J2=7.7 Hz), 4.26 (1H, dd, J1=13.1 Hz, J2=5.4 Hz), 7.10 (1H, d, J=8.5 Hz), 7.22-7.29 (2H, m), 7.39 (1H, t, J=7.4 Hz), 7.49 (2H, t, J=8.0 Hz), 7.56-7.59 (1H, m), 7.69 (1H, d, J=2.5 Hz). LC-MS (ESI) calcd for C22H22N4O6S2 502.10, found 503.2 [M+H+].

Workup

  1. customThe solvent was removed in vacuo
  2. dissolutionThe crude material was redissolved in ethyl acetate (75 mL)
  3. washwashed twice with 1.0 M aqueous hydrochloric acid solution (50 mL)
  4. dry with materialThe organic layer was then dried over sodium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. dissolutionThe crude intermediate was redissolved in ethanol (5 mL)
  8. stirringstirred for 2 h at 60° C
  9. temperatureto cool to 25° C.
  10. customthe solvents were removed in vacuo
  11. custompurified by prep-HPLC [Column Luna 5μ C18 (2) 100 Å AXIA 50×21.2 mm, 5 micron, 30%-90% in 7 min

Sources & evidence

ORD record
ord-0d9fa6d108544fa28684f3591e0aaee6
Source dataset
uspto-grants-2009_09
Patent number
US07582626B2

Reaction notes

Loading…